Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Documentation in relation to drug management

Joanna Black

OCTRU

Tuesday, 27 June 2017, 10am to 12pm

Botnar Research Centre, Room G54

This session will cover the following:

  • Understanding the documentation required in relation to IMP for requesting Trial Authorisation
  • Understanding the need for Manufacturing licence for IMPs
  • Understanding the difference between QP Declaration certificate and QP release certificates
  • The need for Certificate of Analysis documentation
  • Drug accountability logs.
  • Special licence for the use of Specials
  • The difference between an IMP and a NIMP

 

Places need to be booked on this course.

Please email octrutrialshub@ndorms.ox.ac.uk to book.